Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue
+13.9%
EPS
+8.21%
Free cash flow
+99.6%
Total debt
−11.2%

Quarter to September 2026, against a year earlier

46.81 0.66 −1.39%
Market cap
$111.8B
P/E
23.2×
Fwd P/E
—
Dividend yield
5.18%
F-score
7/9
Altman Z
2.50
Beneish M
−2.63
Dividend safety
54/100

Sanofi (SNY) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Sanofi (SNY) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 1.2× (October 2026) to 2.3× (August 2015); the current reading is higher than 7% of that period. That is below the Drug Manufacturers General industry median of 5.2× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.5× 1.75%
FY2024 1.4× (7.88%)
FY2023 1.6× 0.38%
FY2022 1.5× (4.06%)
FY2021 1.6× 2.15%
FY2020 1.6× (16.67%)
FY2019 1.9× 18.03%
FY2018 1.6× (2.79%)
FY2017 1.7× 0.08%
FY2016 1.7× (6.81%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 1.2× (3.07%)
Jun 2026 1.3× (11.75%)
Mar 2026 1.4× (1.90%)
Dec 2025 1.5× 1.15%
39 more quarters

Against its own ten years

Low 1.2× High 2.3×
Ten-year median 1.7×
Current reading's percentile 7

P/B ratio against peers

Company P/B ratio
SNY Sanofi 1.4×
PFE Pfizer Inc. compare 1.9×
GSK GSK PLC Sponsored ADR compare 4.1×
NVO Novo Nordisk A/S compare 5.2×
BMY Bristol Myers Squibb Company compare 5.5×
AZN AstraZeneca PLC compare 5.6×
NVS Novartis AG compare 8.2×
GILD Gilead Sciences, Inc. compare 16.1×
AMGN Amgen Inc. compare 21.4×
Drug Manufacturers General industry median 5.2×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on SNY